Overview
Employees
11-50
Investment Type
Venture Capital
Portfolio 72
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| Jun 5, 2023 | ArriVent Biopharma | arrivent.com | $415M | United States, Pennsylvania, Newtown Township |
| Aug 26, 2022 | Numab Therapeutics | numab.com | $347.38M | Switzerland, Zurich, Wädenswil |
| Aug 26, 2022 | C-Ray Therapeutics | c-raytherapeutics.com | ||
| Aug 26, 2022 | Mahzi | mahzi.com | Costa Rica | |
| Aug 26, 2022 | Upstream Bio | upstreambio.com | $400M | United States, Massachusetts, Waltham |
| Arrakis Therapeutics | arrakistx.com | $113M | United States, Massachusetts, Waltham | |
| Galera Therapeutics, Inc. | galeratx.com | $260M | United States, Pennsylvania, Malvern | |
| MicroOptx | microoptx.com | United States, Minnesota, Maple Grove | ||
| C4 Therapeutics | c4therapeutics.com | $243M | United States, Massachusetts, Watertown |
Show more
Mentions in press and media 10
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 20, 2021 | Numab Therapeutics Completes CHF 100 Million Series C Financing | Numab Therapeutics aims to write the next chapter in cancer immunotherapy by creating multi-specific antibodies that enable the pursuit of novel therapeutic strategies. Its lead product was designed to balance potent anti-tumor immunity wit... |
| May 20, 2021 | Numab Therapeutics Completes CHF 100 Million Series C Financing | |
| Oct 2, 2020 | Can Pharma-Biotech Alliances Solve The Innovation Crisis And Save The Industry? | Pharma cannot make enough new medicines to meet the needs of patients. (AP Photo/Elise Amendola)ASSOCIATED PRESS |
| Mar 31, 2015 | Applied Pharma Research Receives Minority Investment from HBM Partners | APR Applied Pharma Research s.a., a Balerna, Switzerland-based developer of science driven, patent protected Healthcare products, received a minority investment from HBM Partners. The amount of the deal was not disclosed. As part of it, Val... |
| Feb 20, 2013 | Gynesonics Completes $21M Series D | REDWOOD CITY, CA, Healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids, announced a Series D financing led by HBM Partners based in Switzerland. >> Click here for more funding data on Gynesoni... |
| Feb 20, 2013 | Gynesonics Raises $21M Series D Funding | Gynesonics Inc., a Redwood City, California-based women’s healthcare company, raised a $21m Series D funding. The round was led by HBM Partners, with participation new investor Correlation Ventures and existing investors Abingworth, Advance... |
| Jan 21, 2013 | HBM investiert in Medtech Start-up Reha Technology | |
| Oct 2, 2012 | Percutaneous spinal implant maker Interventional Spine raises $1.6 million | Location: Irvine, California Solution/Product: The company makes several products for U.S. and overseas markets. Its most recent product is the FDA cleared PerX360° system that makes it possible to have a spinal fusion via two incisions tha... |
| Percutaneous spinal implant maker Interventional Spine raises $1.6 million | Interventional Spine, that has developed spinal implants that can be delivered percutaneously, raised $1.6 million by issuing debt. Here are the details: Industry: Medical devices Location: Irvine, California Solution/Product: The company m... |
Reviews 0
FAQ about HBM Partners
How many startups has HBM Partners invested in?
HBM Partners has 72 portfolio companies on Parsers VC, among them ArriVent Biopharma, Numab Therapeutics and C-Ray Therapeutics.
What has the press written about HBM Partners?
Parsers VC has collected 10 articles mentioning HBM Partners, among them “Numab Therapeutics Completes CHF 100 Million Series C Financing” (May 20, 2021) and “Numab Therapeutics Completes CHF 100 Million Series C Financing” (May 20, 2021).
Is HBM Partners still active?
Yes, HBM Partners is active; its latest activity on Parsers VC dates from May 28, 2024.